Koers Titan Medical Inc. Toronto S.E.
Aandelen
CA88830X1087
Geavanceerde medische apparatuur & technologie
Omzet 2022 | - | Omzet 2023 | 17,63 24,02 16,23 | Marktkapitalisatie | 6,87 mln. 9,36 mln. 6,33 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -42 mln. -57,2 mln. -38,67 mln. | Nettowinst (verlies) 2023 | 6 mln. 8,17 mln. 5,52 mln. | EV/omzet 2022 | - |
Nettoliquiditeiten 2022 | 1,58 mln. 2,15 mln. 1,45 mln. | Nettoliquiditeiten 2023 | 6,27 mln. 8,54 mln. 5,77 mln. | EV/omzet 2023 | 34.203 x |
K/w-verhouding 2022 |
-1,74
x | K/w-verhouding 2023 |
1,01
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 99,58% |
Recentste transcriptie over Titan Medical Inc.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Paul Cataford
CEO | Chief Executive Officer | 60 | 30-09-20 |
Chien Huang
DFI | Director of Finance/CFO | - | - |
Cary Vance
BRD | Director/Board Member | 58 | 30-09-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Paul Cataford
CEO | Chief Executive Officer | 60 | 30-09-20 |
Director/Board Member | 67 | 30-09-20 | |
Cary Vance
BRD | Director/Board Member | 58 | 30-09-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,91% | 227 mld. | |
+15,46% | 198 mld. | |
+18,58% | 142 mld. | |
+30,36% | 111 mld. | |
+0,23% | 64,16 mld. | |
+17,74% | 54,1 mld. | |
+5,82% | 51,41 mld. | |
+11,23% | 45,32 mld. | |
+5,73% | 37,32 mld. |